Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1033 word(s) 1033 2021-12-02 03:38:47 |
2 format correct Meta information modification 1033 2021-12-14 08:28:58 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Abd Eldaim, M. Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract. Encyclopedia. Available online: (accessed on 15 June 2024).
Abd Eldaim M. Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract. Encyclopedia. Available at: Accessed June 15, 2024.
Abd Eldaim, Mabrouk. "Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract" Encyclopedia, (accessed June 15, 2024).
Abd Eldaim, M. (2021, December 14). Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract. In Encyclopedia.
Abd Eldaim, Mabrouk. "Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract." Encyclopedia. Web. 14 December, 2021.
Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract

Ceratonia siliqua (Carob) is an evergreen Mediterranean tree, and carob pods are potentially nutritive and have medicinal value. 

Ceratonia siliqua carob flavonoids polyphenols antihemolytic antimicrobial

1. Introduction

Plants are of great interest in drug discovery and are the main source of our modern medicine. About 25% of modern medicines are derived from a plant origin and only 5–15% of plants are being investigated for their medicinal use [1]. Today, medicinal herbs and functional foods are being widely studied resulting in lucrative therapeutic potentials [2]. Where the secondary metabolites, which possessed antioxidant properties can fight several pathological disorders such as cancer, heart disease, hypertension, dementia, and stroke [3]. However, chemotherapies have many adverse effects; several anti-diabetic drugs such as Rosiglitazone and Alogliptin can have severe complications. Therefore, scientists have tried to find naturally occurring anti-diabetic compounds as they have low toxic effects [4]. In addition, the WHO has stated that if there is no action taken to develop/find new antibiotic agents, the deaths due to infection resistance will be greater than cancer [5]. Bacteria develop resistance against antibiotics due to the presence of multi-drug resistance (MDR) pumps which are predominant in Staphylococcus aureusPseudomonas aeruginosaEscherichia coli, etc. Therefore, researchers are trying to find MDR inhibitors, especially those derived from medicinal plants, due to their diversity to increase the efficacy of antibiotics [6].
Ceratonia siliqua L., Carob, is an evergreen tree that belongs to the Leguminosae family. It is widely cultivated in most Mediterranean basin countries [7]. The carob fruit (bean) is called a pod and is composed of two parts: the seeds (10%) and the pulp (90%). The pulp consists of two parts: a leathery outer layer (pericarp) and a softer inner area (mesocarp) which contain the seeds [8][9]. Carob pulp contains a wide range of biologically active compounds, including polyphenols, sugars, cyclitols, amino acids, fibers, and minerals, whereas carob seeds contain gum, polyphenols, and proteins [10]. Due to its chemical composition, carob and its ethanolic extract have a strong antioxidant activity and possess several valuable therapeutic functions, such as lipid-lowering [11], anti-proliferative, anti-cardiovascular [12], and nephroprotective properties [13]. In addition, carob has exhibited significant pharmacological activities in the digestive tract including antidiarrheal, antibacterial, anti-ulcer, and anti-inflammatory actions, and possesses a laxative effect on gastrointestinal propulsion [14].

2. The Phytochemical Ingredients of the CPAE

The phytochemical analysis revealed that CPAE contained many active compounds including total phenolics, flavonoids, carbohydrates, amino, acids, and alkaloids (Table 1).
Table 1. Quantitative phytochemical component of the carob pod aqueous extract.
Parameters Concentration
Total flavonoids (Rutin/100 mg CPAE) 0.752 ± 0.11
Total phenolics (GA/100 mg CPAE) 0.348 ± 0.07
Total amino acids (mg/mL) 43.28 ± 2.1
Total alkaloids (mg/mL) 15.3 ± 0.98
Total carbohydrates (mg/mL) 5.1 ± 0.23
The value expressed mean ± SE, Gallic acid, GA; carob pod aqueous extract, CPAE.
Moreover, HPLC analyses showed that CPAE contained a high content of gallic acid followed by catechin, protocatechuic acid, and cinnamic acid, while it also contained a low concentration of p-coumaric acid, rutin, gentisic acid, p-hydroxybenzoic acid, vanillic acid, and ferulic (Figure 1 and Table 2).
Figure 1. High-Performance Liquid Chromatography (HPLC) analysis of CPAE.
Table 2. The constituents of carob pod aqueous extract.
Compound Concentration (µg/g) Retention Time
Gallic acid 833.751 3.74
Catechin 180.197 11.67
Protocatechuic acid 110.576 7.98
Cinnamic acid 23.335 39.7
p-coumaric acid 12.707 36.42
Rutin 10.983 35.9
Gentisic acid 3.487 7.04
p-hydroxybenzoic acid 2.731 9.88
Vanillic acid 2.261 17.47
Ferulic acid 2.038 20.79

3. The Antioxidant Effect of CPAE

The antioxidant effect of CPAE was measured in vitro. The scavenging activity of the CPAE was often evaluated according to its IC50; the lowest IC50 value corresponds to the highest free radical scavenging activity. It is obvious that CPAE had DPPH, NO, FRAP, and OH free radical scavenging activities. The CPAE antioxidants properties were lower than those of ascorbic acid which was used as a positive control, at p < 0.05 (Table 3).
Table 3. IC50 of carob pod aqueous extract and ascorbic acid as positive control antioxidants activities.
Parameters CPAE
IC50 (mg/mL)
Ascorbic Acid
IC50 (mg/mL)
DPPH scavenging activity 3.78 ± 0.08 * 1.59 ± 0.01
Ferric reducing activity 6.30 ± 0.11 * 4.21 ± 0.25
NO scavenging activity 4.33 ± 0.06 * 3.48 ± 0.31
•OH, scavenging activity 7.07 ± 0.12 * 1.32 ± 0.01
In each raw, CPAE mean with * was significantly difference compared to that of the ascorbic acid mean, at p < 0.05.

4. Anti-Digestive Enzymes Effect of CPAE

The results in Figure 2 revealed that Amylase, Maltase, Sucrase, and Lactase activities were strongly inhibited by CPAE in a concentration-dependent manner.
Figure 2. Anti-digestive enzyme effect of carob pod aqueous extract (CPAE).

5. The Hemolytic Effect of CPAE

Hemolytic activity of CPAE was screened against normal human erythrocytes. Figure 3 showed that the hemolytic percent was increased from 0.7 to 3.2% when the concentration of CPAE increased in the range from 10 mg/mL to 100 mg/mL. The calculated hemolytic IC50 was 1562.5 mg/mL.
Figure 3. The antihemolytic activity of carob pod aqueous extract (CPAE).

6. Anti-Microbial Activity of CPAE

6.1. The Antibacterial Activity against Gram-Negative, Gram-Positive Bacteria and Antifungal Effect

Table 4 shows that the CPAE had a significant antibacterial property against Bacillus subtilisStaph. aureus, and Escherichia coli. However, CPAE did not show any activity against Gram-negative bacteria Pseudomonas aeruginosa. Moreover, it exhibited a potent antibacterial effect compared to that of gentamicin (positive control antibiotic) in the case of Staphylococcus aureus and Escherichia coli with ZOI (25 and 24 mm, respectively). In addition, the extract exhibited an antifungal effect against Candida albicans, while it did not show any activity against Aspergillus falvus Table 4.
Table 4. Antimicrobial activity of carob pod aqueous extract.
Pathogenic Microorganism Inhibition Zoon (mm)
CPAE Postive Control
Bacillus subtilis (ATCC 6051) 17.0 ± 0.12 * 25.0 ± 0.3
Staph. aureus (ATCC 6538) 25.0 ± 0.2 * 15.0 ± 0.11
Escherichia coli (ATCC 8739) 24.0 ± 0.3 * 17.0 ± 0.09
Pseudomonas aeruginosa (ATCC 90274) N.A 22.0 ± 0.12
Candida albicans (ATCC 10221) 15 ± 0.13 N.A
Aspergillus falvus (ATCC 9643) N.A N.A
In each raw, CPAE mean with * was significantly difference compared to that of gentamicin mean, at p < 0.05. N.A: No activity, positive control is gentamicin, Carob pod aqueous extract, CPAE.

6.2. Antiviral Activity of CPAE

Table 5 indicated that the CPAE was considered safe for Vero cells until 5000 µg/mL where cell viability was 96.5%. Moreover, our results showed that CPAE inhibited HSV-1 in a concentration-dependent manner (Table 6).
Table 5. Effect of carob pod aqueous extract on Vero cells viability.
Concentration (µg/mL) Viability %
10,000 39.4 ± 0.01 a
5000 96.5 ± 0.05 b
2500 97.4 ± 0.02 b
1250 99.0 ± 0.04 c
625 99.8 ± 0.05 c
312.5 100.0 ± 0.08 c
IC50 9154.22
The value expressed mean ± SE. Means with different superscript letters were significantly different at p < 0.05. Mean with letter (a) was the lowest one while mean with letter (c) was the highest one.
Table 6. Effect of carob pod aqueous extract on the viability of Vero cells infected with HSV-1.
μg/mL Viability Antiviral Effect %
0 37.94 0.00
1250 40.78 4.58 ± 0.01 a
2500 50.40 20.08 ± 0.25 b
5000 66.80 46.50 ± 1.5 c
Value expressed mean ± SE. Means with different superscript letters were significantly different at p < 0.05. Mean with letter (a) was the lowest one while mean with letter (c) was the highest one.


  1. Khan, F.; Sarker, M.M.R.; Ming, L.C.; Mohamed, I.N.; Zhao, C.; Sheikh, B.Y.; Tsong, H.F.; Rashid, M.A. Comprehensive review on phytochemicals, pharmacological and clinical potentials of gymnema sylvestre. Front. Pharmacol. 2019, 10, 1–19.
  2. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; Orhan, I.E.; Banach, M.; Rollinger, J.M.; Barreca, D.; Weckwerth, W.; Bauer, R.; Bayer, E.A.; et al. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216.
  3. Fanzo, J.; Hunter, D.; Borelli, T.; Mattei, F. Diversifying Food and Diets: Using Agricultural Biodiversity to Improve Nutrition and Health; Routledge: London, UK, 2013; ISBN 1136461469.
  4. He, J.-H.; Chen, L.-X.; Li, H. Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets. Fitoterapia 2019, 134, 270–289.
  5. Longhi, S.; Monteriù, A.; Freddi, A.; Aquilanti, L.; Ceravolo, M.G.; Carnevali, O.; Giordano, M.; Moroncini, G. The First Outstanding 50 Years of “Università Politecnica delle Marche”: Research Achievements in Life Sciences; Springer: Cham, Switzerland, 2020; ISBN 9783030338329.
  6. Sibanda, T.; Okoh, A.I. The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr. J. Biotechnol. 2007, 6, 1684–5315.
  7. Santonocito, D.; Granata, G.; Geraci, C.; Panico, A.; Siciliano, E.A.; Raciti, G.; Puglia, C. Carob seeds: Food waste or source of bioactive compounds? Pharmaceutics 2020, 12, 1090.
  8. Fidan, H.; Stankov, S.; Petkova, N.; Petkova, Z.; Iliev, A.; Stoyanova, M.; Ivanova, T.; Zhelyazkov, N.; Ibrahim, S.; Stoyanova, A. Evaluation of chemical composition, antioxidant potential and functional properties of carob (Ceratonia siliqua L.) seeds. J. Food Sci. Technol. 2020, 57, 2404–2413.
  9. Rasheed, D.M.; El-Kersh, D.M.; Farag, M.A. Ceratonia siliqua (carob-locust bean) outgoing and potential trends of phytochemical, economic and medicinal merits. In Wild Fruits: Composition, Nutritional Value and Products; Springer: Cham, Switzerland, 2019; pp. 481–498.
  10. Zhu, B.-J.; Zayed, M.Z.; Zhu, H.-X.; Zhao, J.; Li, S.-P. Functional polysaccharides of carob fruit: A review. Chin. Med. 2019, 14, 1–10.
  11. Zunft, H.J.F.; Lüder, W.; Harde, A.; Haber, B.; Graubaum, H.-J.; Gruenwald, J. Carob pulp preparation for treatment of hypercholesterolemia. Adv. Ther. 2001, 18, 230–236.
  12. Corsi, L.; Avallone, R.; Cosenza, F.; Farina, F.; Baraldi, C.; Baraldi, M. Antiproliferative effects of Ceratonia siliqua L. on mouse hepatocellular carcinoma cell line. Fitoterapia 2002, 73, 674–684.
  13. Rtibi, K.; Selmi, S.; Jabri, M.-A.; El-Benna, J.; Amri, M.; Marzouki, L.; Sebai, H. Protective effect of Ceratonia siliqua L. against a dextran sulfate sodium-induced alterations in liver and kidney in rat. J. Med. Food 2016, 19, 882–889.
  14. Rtibi, K.; Selmi, S.; Grami, D.; Amri, M.; Eto, B.; El-Benna, J.; Sebai, H.; Marzouki, L. Chemical constituents and pharmacological actions of carob pods and leaves (Ceratonia siliqua L.) on the gastrointestinal tract: A review. Biomed. Pharmacother. 2017, 93, 522–528.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 505
Entry Collection: Biopharmaceuticals Technology
Revisions: 2 times (View History)
Update Date: 15 Dec 2021
Video Production Service